Yukiko Mikami Tomonori Nagai Yousuke Gomi Yasushi Takai Masahiro Saito Kazunori Baba Hiroyuki Seki
10.1186/s13256-015-0790-6
J Med Case Rep
2016 Jan 18;10:9.
CC BY
https://pubmed.ncbi.nlm.nih.gov/26781485/
Antibiotics, Antineoplastic / therapeutic use Antineoplastic Agents / adverse effects Chorionic Gonadotropin / blood Dactinomycin / therapeutic use Hydatidiform Mole, Invasive / drug therapy Hysterectomy Lung Neoplasms / drug therapy Methotrexate / adverse effects Porphyria, Acute Intermittent / complications Uterine Neoplasms / drug therapy
Antibiotics, Antineoplastic / therapeutic use Antineoplastic Agents / adverse effects Chorionic Gonadotropin / blood Dactinomycin / therapeutic use Hydatidiform Mole, Invasive / drug therapy Hysterectomy Lung Neoplasms / drug therapy Methotrexate / adverse effects Porphyria, Acute Intermittent / complications Uterine Neoplasms / drug therapy Case Reports Antineoplastic Agents / administration & dosage Drug Eruptions / drug therapy Drug Eruptions / etiology Female Humans Hydatidiform Mole, Invasive / secondary Hydatidiform Mole, Invasive / surgery Lung Neoplasms / secondary Methotrexate / administration & dosage Middle Aged Pregnancy Treatment Outcome Uterine Neoplasms / pathology Uterine Neoplasms / surgery Antibiotics, Antineoplastic Antineoplastic Agents Chorionic Gonadotropin Dactinomycin Methotrexate
PMC4717627
26781485
Methotrexate and actinomycin D chemotherapy in a patient with porphyria: a case report
2016